论文部分内容阅读
目的:观察15例肝硬化失代偿期脾功能亢进(简称脾亢)患者脾内无水酒精注射治疗的疗效。方法:经皮脾内注射无水酒精治疗15例脾亢患者。从小剂量0.5ml开始,然后根据患者外周血象变化逐渐增加无水酒精的剂量。结果:经皮脾内注射无水酒精,能够改善脾亢,15例患者治疗前血小板平均值为(44±13)×10~9/L,治疗后两周血小板计数平均值增加至130±10~9/L(P<0.01)。结论:经皮脾内注射无水酒精术操作简便直观,疗效肯定,是脾亢安全、合理的非手术治疗方法。
Objective: To observe the curative effect of 15 cases of splenic anhydrous ethanol injection in 15 patients with decompensated cirrhosis and hypersplenism (referred to as hypersplenism). Methods: 15 cases of hypersplenism were treated by percutaneous spleen injection of anhydrous alcohol. Starting from a small dose of 0.5ml, and then according to the patient’s peripheral blood changes gradually increase the dose of anhydrous alcohol. Results: Percutaneous spleen injection of anhydrous alcohol could improve hypersplenism. The average value of platelet before treatment in 15 patients was (44 ± 13) × 10 ~ 9 / L, and the average value of platelet count increased to 130 ± 10 ~ 9 / L (P <0.01). Conclusion: Intraperitoneal injection of anhydrous alcohol surgery is simple and intuitive, and its curative effect is affirmative. It is a safe and reasonable non-surgical treatment for hypersplenism.